Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference

Rhea-AI Summary

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that its CEO, Scott Tarriff, and CFO, Brian Cahill, will present at the William Blair 42nd Annual Growth Stock Conference on June 9, 2022, at 9:40 AM ET. The conference highlights Eagle's commitment to developing innovative medicines aimed at improving patient outcomes. The company’s portfolio includes products like vasopressin injection and BENDEKA, along with a strong pipeline in oncology and CNS/metabolic critical care. For more details, visit Eagle's website.

News Market Reaction – EGRX

+4.33%

+4.33% Session move

In the trading session that priced this news, EGRX gained 4.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WOODCLIFF LAKE, N.J., May 26, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the William Blair 42nd Annual Growth Stock Conference as follows:

Date:	Thursday, June 9, 2022
Time:	9:40AM ET/8:40AM CT
Webcast:	Click Here

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include vasopressin injection, PEMFEXY^™, RYANODEX^®, BENDEKA^®, BELRAPZO^®, TREAKISYM (Japan), and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

Investor Relations for Eagle Pharmaceuticals, Inc.:

Lisa M. Wilson        
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

 

FAQ

When will Eagle Pharmaceuticals present at the William Blair Conference?

Eagle Pharmaceuticals will present on June 9, 2022.

What time is the Eagle Pharmaceuticals' presentation at the conference?

The presentation is scheduled for 9:40 AM ET.

Who will represent Eagle Pharmaceuticals at the William Blair Conference?

Scott Tarriff, CEO, and Brian Cahill, CFO, will represent Eagle.

Where can I watch the Eagle Pharmaceuticals conference presentation?

You can watch the presentation via the webcast available here.

What products does Eagle Pharmaceuticals offer?

Eagle offers products like vasopressin injection, BENDEKA, and RYANODEX, among others.